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Abstract
Background: Transposable Elements (TEs) comprise nearly 45% of the entire genome and are part of sophisticated
regulatory network systems that control developmental processes in normal and pathological conditions. The retroviral/
retrotransposon gene machinery consists mainly of Long Interspersed Nuclear Elements (LINEs-1) and Human Endogenous
Retroviruses (HERVs) that code for their own endogenous reverse transcriptase (RT). Interestingly, RT is typically expressed at
high levels in cancer cells. Recent studies report that RT inhibition by non-nucleoside reverse transcriptase inhibitors
(NNRTIs) induces growth arrest and cell differentiation in vitro and antagonizes growth of human tumors in animal model. In
the present study we analyze the anticancer activity of Abacavir (ABC), a nucleoside reverse transcription inhibitor (NRTI), on
PC3 and LNCaP prostate cancer cell lines.
Principal Findings: ABC significantly reduces cell growth, migration and invasion processes, considerably slows S phase
progression, induces senescence and cell death in prostate cancer cells. Consistent with these observations, microarray
analysis on PC3 cells shows that ABC induces specific and dose-dependent changes in gene expression, involving multiple
cellular pathways. Notably, by quantitative Real-Time PCR we found that LINE-1 ORF1 and ORF2 mRNA levels were
significantly up-regulated by ABC treatment.
Conclusions: Our results demonstrate the potential of ABC as anticancer agent able to induce antiproliferative activity and
trigger senescence in prostate cancer cells. Noteworthy, we show that ABC elicits up-regulation of LINE-1 expression,
suggesting the involvement of these elements in the observed cellular modifications.
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Introduction
Cancerisa complex disease and itsextreme phenotypevariability
can not be exhaustively described and explained solely by the gene-
environment interactions. Unexpectedly, the completion of the
human genome reveals that the true complexity of the genome has
little to do with the number and heterogeneity of its genes.
Only 2% of the human genome codes for proteins, while the
45% consists of Transposable Elements (TEs) [1]. The TEs,
initially thought to be mere intracellular parasites, were termed
selfish or ‘‘junk’’ DNA, until further research revealed how this
huge amount of non-protein-coding sequences scales up with
organisms complexity, playing a critical role as a part of regulatory
toolkit of the genome, by altering gene expression and driving
genome evolution as well as the development of an organism [2–
10]. TEs can be separated into two major classes: DNA-
transposons (2.8%) and retrotransposons (42.2%). DNA-transpo-
sons amplify without an RNA intermediate, while retrotranspo-
sons rely on an RNA transcript that self-replicates with the aid of a
reverse transcriptase (RT).
RTs encoded by Long Interspersed Nuclear Element-1 (LINE-
1) and Human Endogenous Retroviruses (HERVs) were found to
be associated with pathological and physiological processes. In
particular, high expression levels of RT were found in germ cells,
embryos, undifferentiated and transformed cells, while in differ-
entiated non-pathological tissues they were barely expressed,
suggesting a direct correlation with the proliferative potential of
the cell [11–17].
Previous studies have demonstrated that a class of non-
nucleoside RT inhibitors (NNRTIs), widely used in AIDS therapy,
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human cancer cell lines, reducing the cell growth rate and
inducing differentiation [18–20]. Furthermore, the same biological
effects were reproduced in RNA interfering experiments with
specific siRNA directed against LINE-1 and HERV-K. These
results clearly indicate that both classes of retroelements are linked
in a functional network, involved in cell growth and tumorigenesis,
but with distinct hierarchical roles, being LINE-1 able to control
HERV-K expression [21]. These studies suggest that endogenous
non-telomeric RT may represent a novel target in the develop-
ment of therapeutic anticancer agents.
NNRTIs bind to a hydrophobic pocket, near to the RT active
site. The binding induces a conformational change in the protein,
affecting its affinity for the substrate and, consequently, inhibiting
RT enzymatic activity. NNRTIs are classified as allosteric non-
competitive RT inhibitors.
Another class of antiretroviral inhibitors that target RT is
represented by the nucleoside reverse transcription inhibitors
(NRTIs). Compared to the NNRTIs, they have a different
mechanism of action. The NRTIs are nucleotide analogues that
inhibit reverse transcription by being incorporated into the newly
synthesized viral DNA (cDNA) and preventing its further
elongation. They are classified as non-allosteric competitive
substrate inhibitors. Among these, Abacavir (ABC) is successfully
used in combination with other antiviral drugs in the treatment of
HIV infection. It is converted by cellular enzymes to the active
carbovir triphosphorilated form, an analogue of dGTP. With
respect to other NRTIs, ABC shows a very low affinity for cellular
DNA polymerases [22]. Additionally, Jones et al. [23] demon-
strated with an in vitro LINE-1 retrotransposition assay that NRTIs
have the ability to suppress LINE-1 retrotransposition, indicating
the susceptibility of LINE-1 RT to this class of drugs.
Based on these evidences, we have investigated the antitumor
activity of ABC on the hormone-dependent LNCaP and hormone-
refractory PC3 prostate cancer cell lines. These metastatic cells are
generally assumed to represent early and late stages of prostate
cancer respectively. Until now, prostate cancer represents the most
common noncutaneous cancer in man in the United States [24].
The mainstay treatment is the androgen ablation, but after an
initial good response the disease progresses to hormone-refractory
prostate cancer [25]. New therapy modalities are needed to
prevent or treat this more lethal form of prostate cancer.
Here we demonstrate that ABC induces a significant decrease in
cell growth rate and a delay of the cell cycle in S phase. A high
percentage of senescent cells were observed and many of them were
committed to death. Few hours of ABC exposure significantly
reduced the potential of migration and invasion in prostate cancer
cells. Moreover, a genome-wide expression analysis on PC3 cells
revealed a dose-dependent gene regulation. Notably, ABC was able
to modulate LINE-1 expression in both cell lines.
Materials and Methods
Cell Cultures and Treatments
The human prostate cancer cell lines PC3 (ATCC CRL-1435)
and LNCaP (ATCC CRL-1740) and the non-transformed human
fibroblast cell line WI-38 (ATCC CCL-75) were cultured
according to the ATCC recommendations. Abacavir was purified
from commercially available Ziagen tablets (GlaxoSmithKline,
Research Triangle Park, NC 27709) by methanol extraction and
purification grade assessed by HPLC. For drug experiments, ABC
was dissolved in FBS-free medium and used at the concentration
of 15 or 150 mM. Drug-containing fresh medium was changed
every 48 h. For synchronization experiments cells were treated
with 2 mg/ml aphidicolin for 18 h, then washed twice with PBS
and released in fresh medium, containing or not ABC.
RT Activity Assay
RT activity assays were performed by a minor modification of
the method described by Mangiacasale et.al [18]. Cells (5610
5–
10
6) were lysed in 40 ml ice-cold lysis buffer (10 mM Tris-HCl pH
7.5, 1 mM MgCl2, 1 mM EGTA, 0.1 mM PMSF, 5 mM b-
mercaptoethanol, 0.5% CHAPS, 10% glycerol). After three freeze-
and-thaw cycles, cells were incubated for 30 min on ice and
centrifuged for 30 min at 14 000 r.p.m. at 4uC. RT activity was
tested using a ThermoScript RT–PCR system (Invitrogen) in 20 ml
reactions containing 10 ng of MS2 phage RNA (Roche Diagnos-
tics) and 30 pmol of MS2 reverse primer (see below) and sub-
stituting commercial RT with cell-free extract (24 mg total protein).
Reaction mixtures were incubated at 55uC for 1 h followed by
5 min at 85uC. A 1 ml volume of Escherichia coli RNaseH (2 U/ml)
was added to each sample and further incubated at 37uC for
20 min. Control reactions were set up by omitting cell extract
(negative control), or adding 1 ml of ThermoScript RT (Invitrogen)
(15 U/ml, positive control). A 2 ml volume from each reaction was
mixed with 30 pmol each of forward (59-TCCTGCTCAACTT-
CCTGTCGAG-39) and reverse (59-CACAGGTCAAACCTCC-
TAGGAATG-39) MS2 primers and PCR-amplified using the
Platinum PCR SuperMix (Invitrogen). PCR conditions were as
follows: 94uC for 2 min, followed by 30 cycles of 94uC for 30 s,
58uC for 30 s and 72uC for 30 s. The amplification product is a
112-bp DNA fragment spanning positions 21–132 at the 59 end of
the MS2 RNA (GenBank V00642). PCR products were
fractionated through 1.5% agarose gel electrophoresis.
Cell Proliferation Assay
PC3, LNCaP and WI-38 cells were seeded at a density of
20,000 per well in 12-well plates, cultured for 24 h and then
treated with ABC at the concentration of 15 or 150 mM. At 0, 24,
48, 72 and 96 h the number of trypan blue-excluding cells were
counted in a Burker chamber. The experiments were performed
three times in triplicate.
Cell Cycle Analysis
Treated and untreated cells were harvested by trypsinization
and washed with ice-cold PBS. DNA staining was performed by
using the Cycle TEST
TM PLUS DNA Reagent Kit (Becton &
Dickinson). Cells were then analysed on a FACScan flow
cytometer (Becton & Dickinson).
Senescence Determination
Percentage of senescent cells was measured by detecting b-
galactosidase activity at pH 6 with the Calbiochem Senescence
Detection Kit. Data were quantified from more than 500 cell
counts in three independent experiments.
Fluorescence Microscopy
For morphometric analysis of the nuclei, treated and untreated
cells were fixed with 3% paraformaldehyde and incubated with
Hoechst 33258 solution (1 mg/ml) for 30 min at 37uC. For the
staining of nucleoli, cells grown on 12 mm glass coverslips were
fixed and permeabilized with methanol at 220uC for 10 min,
incubated with antinuclear serum from an autoimmune patient
(kindly provided by Dr. Maria Antonietta Amendolea) and then
incubated with a fluorescein-linked goat anti-human IgG (Bio-
Rad). The samples were analyzed by a CCD camera Nikon
equipped Optiphot microscope (Tokyo, Japan). The morphomet-
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Rasband, NIH, USA). For the statistical analysis Student’s t -test
was applied.
Scanning Electron Microscopy (SEM)
Treated and untreated PC3 cells were fixed with 2%
glutaraldehyde in 0.1 M cacodylate buffer pH 7.4 at room
temperature for 30 min, post-fixed with 1% OsO4 in the same
buffer, dehydrated through a graded ethanol series, critical point
dried with CO2 and gold coated by sputtering. Samples were
examined with a Cambridge Stereoscan 360 scanning electron
microscope (Cambridge Instruments Ltd, Cambridge, UK).
Cell migration and invasion assays
Assays were performed by a modification of the method
described by Albini and colleagues [26]. For migration and
invasion assays, filters 8.0 mm pore (Falcon) were used. Cells,
harvested and suspended in RPMI at a concentration of 1610
6
cells/ml, were added to each filter and 3 ml of RPMI containing
10% FBS were added to the well underneath the insert. For
invasion assay filters were coated with Matrigel
TM (Sigma) diluted
to 1 mg/ml in serum-free RPMI medium. Cells were incubated at
37uC for 18 h. Afterwards, the inner side of the filter was wiped
with a wet swab to remove the cells while the outer side of the
insert was rinsed with PBS and stained with 0.25% crystal violet
(Sigma) for 10 min. The filters were then viewed under a CCD
camera Nikon equipped Optiphot microscope (Tokyo, Japan) and
the percent of area occupied by migrated or invading cells was
analyzed by Optilab software (Graftek Mirmande, France).
Microarray Analysis
Total RNA was isolated using RNase Kit (Qiagen). For each
sample, 500 ng of RNA were synthesized to biotinylated cRNA
using Illumina RNA Amplification Kit (Ambion, Inc., Austin,
TX). RNA and cDNA concentration was determined with a
Nanodrop spectrophotometer (NanoDrop, Wilmington, Dela-
ware, USA) and its quality was assessed with an Agilent 2100
Bioanalyzer (Agilent Technologies, Milano, Italy). From each
sample, technical replicates were produced and 750 ng cRNA
were hybridized for 18 h to HumanRef-8 v2 Expression
BeadChips (Illumina Inc., San Diego, CA, USA) according to
the manufacturer’s protocol. Intensity files were loaded into the
Illumina BeadStudio 3.0.19.0 software and normalized with the
average algorithm. Technical replicates of each sample were
grouped together and genes with a detection p-value ,0.05 were
considered as detected. Genes with Diff Score of 640 (p-value of
0.0001) were considered as differentially expressed genes. Micro-
array data are MIAME compliant and the raw data have been
deposited in the ArrayExpress database (http://www.ebi.ac.uk/
microarray-as/ae), with Accession number: E-TABM-532.
Ingenuity Pathway Analysis 7 (Ingenuity SystemsH, www.
ingenuity.com) was used to analyze the biological relationship of
differentially expressed genes. The biological functions were
evaluated according to the directions of the software. Fisher’s
exact test was used to calculate a p-value determining the
probability that each biological function assigned to that data set
is due to chance alone. A GO (Gene Ontology) enrichment
analysis was also performed using DAVID software [27,28].
RT Assay and Quantification of LINE-1 mRNA Expression
Total RNA was isolated from cells untreated and treated with
15 and 150 mM ABC from 24, to 120 h. RNA was treated with
TURBO DNase (Ambion) to remove contaminating genomic
DNA. cDNAs were synthesized by the TaqMan High Capacity
cDNA Reverse Transcription Kit (PE Applied Biosystems).
Relative quantification PCR reactions were performed with
TaqMan chemistry. LINE-1 transcripts were detected using
custom primers and FAM-MGB-probes for LINE-1 ORF1 and
ORF2 (PE Applied Biosystems), designed using the Primers
Express software (Table S1). The LINE-1 sequence database used
in this work is the L1base (http://l1base.molgen.mpg.de) [29].
The number of LINE-1 sequences targeted by probes are reported
in Table S1. Each reaction was performed in a final volume of
25 mL containing 1 mL cDNA and 12.5 mL of TaqManH
Universal PCR Master Mix (Applied Biosystems). Amplifications
were performed starting with a 2 min activation step for Amperase
UNG at 50uC, 10 min template denaturation step at 95uC,
followed by 40 cycles at 95uC for 15s and 60uC for 1 min. Pre-
developed TaqMan Assay reagent for GAPDH (4310884E) was
used as endogenous control. Absence of amplification from non-
reverse-transcribed RNA was confirmed to exclude genomic DNA
amplification. Differences in gene expression were calculated by
standard 2
2DDCt method. For the statistical analysis Student’s t test
was applied.
Results
Abacavir inhibits cell growth, affects cell cycle
progression and induces senescence in prostate cancer
cell lines
First, we evaluated endogenous RT activity in human prostate
cancer cells and in non-transformed WI-38 control cells. Cells
extracts were used as RT source to reverse transcribe a synthetic
RNA. As shown in Figure 1A, RT activity was found in PC3 and
LNCaP cells, whereas in WI-38 cells RT activity was at an
undetectable level.
To analyze the effect of ABC on cell proliferation rate, cells
were grown in the presence of the drug at concentrations of 15 and
150 mM. A dose-dependent growth inhibition was observed in
both cell lines (Figure 1B). At 15 mM ABC a considerable
reduction in cell growth was revealed after 72 and 96 h of
treatment in PC3 and LNCaP respectively. The 150 mM
concentration strongly inhibited the growth in both cell lines
(Figure 1B). The cytotoxicity of ABC was also examined in non-
transformed WI-38 cells. Interestingly, we did not find a significant
reduction of cell growth with 15 mM ABC whereas the 150 mM
ABC concentration induced only a 20% of cell growth inhibition
after 120 h (Figure 1B).
To investigate whether ABC could affect the cell cycle
progression, prostate cancer cells were treated with 150 mM
ABC and analyzed at different time points up to 120 h. In PC3
cells a very high accumulation of cells in S phase was seen after 18
and 24 h of treatment (56.3 and 78.6% respectively). This increase
was followed by an augment of G2/M cells which became 23.4–
26.9% of total population upon 96 and 120 h of treatment
(Figure 2A, B). LNCaP treated cells showed predominantly an S
phase accumulation reaching 40.5–54.3% after 48 and 72 h of
treatment, but no G2/M phase increment was observed. Rather, S
phase accumulation seems to remain constant over time
(Figure 2A). To further characterize the S phase alteration, cells
were synchronized in early S phase by exposing them to the DNA
synthesis inhibitor aphidicolin. After release from the aphidicolin
block, cells were treated with 150 mM ABC and analysed for cell
cycle distribution at different time points. Figure 2C, shows that
3 h after release both synchronized control cells had moved
toward the middle S phase, represented by the central peak of the
graph, whereas ABC treated cells showed an evident delayed
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treated cells was still present in late S and G2/M phase, whereas
LNCaP, as expected, showed a trend to accumulate in S phase
(Figure 2C). Noteworthy, ABC was able to lengthen S phase
progression alsoifadded inthemiddleSphase,3 h afteraphidicolin
block release (data not shown). All together these data support the
hypothesis that ABC could specifically affect DNA replication.
Together with proliferation inhibition, a considerable increment
of cell death over a period of 6 days was observed with 150 mM
ABC (Figure 3A, B). To evaluate whether these phenomena were
associated with apoptosis induction or senescence, prostate cancer
cells were treated with 150 mM ABC for 5 days and assessed every
24 h for annexin externalisation, nuclear condensation/fragmen-
tation and ß-galactosidase activity at pH 6. No significant increase
of annexin positive cells or apoptotic nuclei was observed in
treated samples at any time point (data not shown) whereas
senescence associated ß-galactosidase activity was significantly
induced by ABC and increased with time, reaching about 80%
and 50% of positive cells upon 5 days of treatment in PC3 and
LNCaP respectively (Figure 3C, D). Moreover, the comparison
between cellular senescence and cell death kinetics suggests that
the two phenomena are strongly associated. On the contrary, we
did not observe cell death nor differences in senescence level in
WI-38 control cells treated with 150 mM ABC, compared to
untreated cells (data not shown).
Morphological Changes of PC3 Treated Cells
PC3 cells were furtheranalyzed atmorphological level.According
to cell cycle alteration and senescence induction, several cell
morphological changes were observed after exposure to the drug
at both doses. At scanning electron microscopy PC3 cells treated
with 15 mM ABC already displayed a more flattened shape
(Figure 4A a, d) and a hindrance in division process after 48 h
exposure(Figure 4A b,e).Inaddition,treated PC3 cellsshow theloss
of surface microvilli that suggest an effect of the drug on cytoskeleton
organization(Figure 4Ac,f).Atnuclearlevel,morphologicalanalysis
emphasizes the presence of bilobate and enlarged nuclei, with an
increase of the nuclear area becoming evident at 48 h of incubation
with 15 mM ABC and 24 h after treatment with 150 mMA B C
(Figure 4B). Morphometric and statistical analysis indicated that
nuclear areas approximately doubled in 48 h with 150 mMA B C
(TableS2).At nucleolar level significant structuremodifications were
found in the cells exposed for 72 h to both ABC doses. Furthermore,
PC3 treated cells nucleoli appear less compact and in some case
scattered respect to the control (Figure 4C).
Abacavir Inhibits Migration and Invasion
Since PC3 and LNCaP cells are of metastatic origin and possess
a migratory and invasiveness potential, we investigated the effects
of ABC on the motility and invasion processes. Cells were seeded
in transwell chambers in the presence or absence of 15 or 150 mM
ABC, and allowed to migrate for 18 h at 37uC. A dose-dependent
decrease of the area occupied by migrating and invading cells was
observed after ABC treatment (Figure 5A, B). Cell migration was
significantly reduced in prostate cancer cells at 15 and 150 mM
ABC doses (p,0.001). Matrigel cell invasion was significantly
inhibited only at the higher ABC dose (Figure 5B).
Gene Expression Modification Induced by Abacavir in
PC3 treated cells
In attempt to find a gene expression signature underlying the
morphological and functional changes observed in ABC treated
Figure 1. ABC induces a dose-dependent growth inhibition in
prostate cancer cell lines. (A) Endogenous RT activity was detected
in PC3, LNCaP and WI-38 cells as described in material and methods; (+)
positive control reaction with commercial RT. (B) Prostate cancer and
normal human fibroblast WI-38 cells were treated with ABC at the
concentration of 15 and 150 mM and cultured at the indicated time
points. Data shown are representative of at least three independent
experiments; bars, 6 SD.
doi:10.1371/journal.pone.0014221.g001
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PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e14221Figure 2. ABC affects cell cycle progression. (A) Cell cycle distribution of PC3 and LNCaP cells exposed to 150 mM ABC. Cells were harvested at
the indicated time points, incubated with propidium iodide and DNA content was analysed by flow cytometry. The percentage of cells in each phase
is reported. (ND, not done). The data are representative of five independent experiments. (B) A representative experiment of cell cycle progression in
PC3 treated cells. The arrows indicate cell accumulation at G2/M phase. (C) PC3 and LNCaP cells were synchronized in early S phase by aphidicolin
and cell cycle distribution was analyzed in treated (150 mM ABC) and untreated cells.
doi:10.1371/journal.pone.0014221.g002
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cells were analyzed on an Illumina Microarray platform 48 h after
treatment.
Analysis of the microarray data showed that 192 genes out of
12605 detected and 3246 out of 12930, were differentially
expressed (p,0.0001) at 15 and 150 mM ABC concentrations
respectively, most of which resulted up-regulated (Figure 6A and
Table S3).
A function analysis of the differentially expressed genes was
performed using Ingenuity Pathways Analysis (IPA) system
(Figure 6B). Interestingly, the comparative analysis of the top-ten
biological functions shows that the major cellular functions
affected by the treatment were the same for the two concentra-
tions, indicating a specific and dose-dependent effect of the drug.
The functions described in Figure 6B are consistent and
representative of both morphological and functional changes
observed at phenotypical level: recovery of cell death pathways,
alterations of cell cycle and proliferation rate, changes of cellular
morphology. Other significantly affected functions were ‘‘RNA
Post-Transcriptional Modifications’’, ‘‘Gene Expression’’ and
‘‘DNA Replication, Recombination and Repair’’. Genes clustered
in the different functions are listed in Table S4.
The data sets obtained at the two doses were successively
compared in a Venn diagram and 144 genes resulted to be shared
between the two lists (Figure 6C, Table S5). Among them, the
most represented Gene Ontology (GO) terms were identified using
the DAVID ‘‘Functional Annotation Chart’’ tool including the
three categories: Biological Processes, Cellular Components and
Molecular Functions. Functional annotation clusters were identi-
fied for each category, with enrichment scores ranging from 1.33
to 8.63 (Table 1). Interestingly, the GO ‘‘Cellular Component’’
category identified 20 genes all belonging to the nuclear
compartments and specifically to nuclear part, chromatin
remodelling complex and chromosome terms (Table 2).
Abacavir Modulates LINE-1 mRNA Expression
Due to the evidence supporting a relationship between RT
activity, LINE-1 expression and cancer cell reprogramming [18–
21], we decided to investigate the ABC effect on the expression of
this class of retrotransposons. Specifically, LINE-1 consist of a 59
UTR (untranslated region), two open reading frames (ORF1 and
ORF2) and a 39 UTR terminating in a poly (A) tail. ORF1
encodes a protein with RNA binding capacity while ORF2
encodes a protein with endonuclease and reverse transcriptase
functions [7]. The cDNAs obtained from prostate cancer cells,
untreated and treated with the two ABC doses and harvested at
24, 48, 72, 96 and 120 h, were amplified by Real-Time PCR with
primers and probes that recognize conserved regions of LINE-1
ORF1 and ORF2 coding sequences. As shown in Figure 7, a dose
and time-dependent increment of mRNAs expression level was
Figure 3. ABC treatment induces senescence and cell death in prostate cancer cells. (A and B) 5610
4 cells were seeded in 12-well plates
with 150 mM ABC. After 0, 2, 4 and 6 days adherent and floating cells were harvested and resuspended in culture medium containing 0.2% trypan
blue for the count of viable and death cells. (C and D) ß-galactosidase activity was evaluated in PC3 and LNCaP cells treated with 150 mM ABC and
analyzed at different time points.
doi:10.1371/journal.pone.0014221.g003
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cells treated with 15 mM ABC at 48 h. (B) Morphological changes and morphometric analysis of the nuclei stained with Hoechst. Doses and time-
points are indicated. (C) Immunofluorescence of nucleoli stained with anti-nucleus human serum.
doi:10.1371/journal.pone.0014221.g004
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ORF2 transcripts, indicating that LINE-1 could play a role in the
molecular and functional changes observed upon ABC treatment.
Discussion
A large number of evidence has confirmed the association
between high level of endogenous RT expression and trans-
formed/tumoral cell phenotype [11,17]. Previous studies with
allosteric RT inhibitors, NNRTIs, suggest that LINE-1-encoded
RT may be regarded as a novel molecular target in cancer
therapy.
In this work we show the antitumor activity of Abacavir, a
nucleoside reverse transcription inhibitor (NRTI) on PC3 and
LNCaP human prostate cell lines of metastatic origin. Further-
more, we report for the first time that ABC treatment can
modulate the LINE-1 mRNA expression.
ABC significantly reduced cell growth, inducing a delay in cell
cycle S phase progression in prostate cancer cells. This slow down
leads to a consequent arrest in G2/M phase in PC3 cells while
LNCaP cells accumulates in S phase. The effect on cell cycle
became evident few hours after treatment and cells progressively
enter a state of senescence. The appearance of senescence-
associated morphological changes and SA-b-gal expression
increased gradually in PC3 and LNCaP cells reaching 80% and
50% respectively in 5 days with resulting cell death.
Contrasting tumor cell migration and invasion is a central issue
in prostate cancer. It is well known that the presence of metastasis
decreases patient’s likelihood of survival and that the treatment
options currently available are rarely able to cure metastatic forms.
Here we report that together with the effect on cell cycle, ABC
impairs invasion and migration potential of PC3 and LNCaP cells.
Based on the gene expression profiles of PC3 cells, we provide
preliminary insights into the relationship between ABC treatment
and gene patterns involved in specific biological functions. The
IPA analysis of dose-response data generated super imposable
functional clustering at the two ABC concentrations, highlighting
a direct correlation between the gene expression pattern and the
morphological and functional modifications observed. Further
analysis of the 144 differentially expressed genes common to the
two ABC doses, drew attention on the GO-Terms related to the
nuclear compartment and to those genes involved in ‘‘chromatin
remodeling complex’’, which emerge with a high enrichment
score. It can be speculated that ABC could affect the chromatin
status, slowing down S phase and exposing the cells to numerous
endogenous and/or exogenous replication stresses. This condition,
where ABC selectively renders tumor cells more vulnerable to
DNA-damaging agents, may be relevant in strategies that combine
ABC treatment with other conventional cancer therapies.
Similar effects on cell cycle alteration and senescence induction
were previously reported by Rossi et al. [30] in medulloblastoma
ABC treated cells. The authors observed a cell growth inhibition
with the appearance of senescence features after one week of 350–
750 mM ABC treatment, associating these phenomena to the
down-regulation of telomerase activity. Nevertheless, it must be
noted that in our experimental model we observed a prompt
slowdown of S phase and an early appearance of senescence
phenotype with 150 mM ABC. Since senescence elicited by
inhibitors of the telomerase-associated RT usually requires a
higher number of replication events [31], we suggest that the
senescence induced by ABC can be dependent on the effect
exerted on endogenous RT of non-telomeric origin.
The most characterized and abundant retrotransposons in the
mammalian genome are LINE-1 sequences. About 79% of
Figure 5. ABC reduces migration and invasion potential of prostate cancer cells. PC3 and LNCaP cells were seeded on the membrane in
presence or absence of Matrigel and incubated with 15 and 150 mM ABC for 18 h. (A) representative image of migrating and invading PC3 cells
stained with crystal violet. (B) Percentage of migration and invasion decrease respect to untreated cells analysed by Optilab software. (*) corresponds
to p,0.001, calculated by the Mann-Whitney test.
doi:10.1371/journal.pone.0014221.g005
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14221Figure 6. PC3 microarray analysis results. (A) Summarizing chart of the expressed and differentially expressed gene numbers resulting from
microarray assay (four biological replicates for each condition). (B) Comparison of the top-ten biological functions at 15 and 150 mM ABC obtained by
IPA analysis. On the y-axis the statistical significance, expressed as -log/p-value, is reported. Threshold p-value =0.05 (yellow line). The number of the
genes involved in each function is reported on the top of each bar. (C) Venn diagram showing the fraction of common genes differentially expressed
in PC3 cells at 15 and 150 mM ABC.
doi:10.1371/journal.pone.0014221.g006
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e14221mammalian genes contain at least one LINE-1 segment in their
transcription unit, mainly within intronic regions, with the poorly
expressed genes containing a larger amount of LINE-1 sequences
respect to the highly expressed genes [32].
Although expression of LINE-1 is barely detected in most
normal somatic cells due to epigenetic suppression, their
expression is elevated in many cancer cells [33,34]. A large body
of data show that LINE-1 retrotransposition can be increased by a
Table 1. DAVID Functional Annotation analysis of the 144 differentially expressed genes.
Category Term
Genes
number % pValue
Fold
enrichment
Biological Process GO:0006979,response to oxidative stress 5 3.57 1.07E-02 5.75
GO:0043412,biopolymer modification 26 18.57 1.91E-02 1.56
GO:0006464,protein modification process 25 17.86 2.10E-02 1.57
GO:0043687,post-translational protein modification 22 15.71 2.21E-02 1.64
GO:0007275,multicellular organismal development 26 18.57 3.88E-02 1.47
GO:0006333,chromatin assembly or disassembly 5 3.57 3.91E-02 3.87
GO:0032502,developmental process 35 25.00 4.76E-02 1.33
Cellular Component GO:0044428,nuclear part 18 12.86 2.59E-02 1.73
GO:0016585,chromatin remodeling complex 3 2.14 4.61E-02 8.63
GO:0005694,chromosome 8 5.71 4.72E-02 2.40
Molecular Function GO:0008047,enzyme activator activity 8 5.71 1.53E-02 3.05
GO:0051082,unfolded protein binding 5 3.57 2.72E-02 4.35
GO:0005524,ATP binding 20 14.29 3.00E-02 1.64
GO:0032559,adenyl ribonucleotide binding 20 14.29 3.34E-02 1.62
GO:0004674,protein serine/threonine kinase activity 9 6.43 3.52E-02 2.36
GO:0016773,phosphotransferase activity, OH as acceptor 12 8.57 4.71E-02 1.91
GO:0016209,antioxidant activity 3 2.14 4.88E-02 8.36
doi:10.1371/journal.pone.0014221.t001
Table 2. List of the genes clustered into the ‘‘Cellular Component’’ ontology term.
GENE_SYMBOL GENE NAME
AHCTF1 AT HOOK CONTAINING TRANSCRIPTION FACTOR 1
ANAPC5 ANAPHASE PROMOTING COMPLEX SUBUNIT 5
BANF1 BARRIER TO AUTOINTEGRATION FACTOR 1
CBX6 CHROMOBOX HOMOLOG 6
CLASP1 CYTOPLASMIC LINKER ASSOCIATED PROTEIN 1
DNAJB9 DNAJ (HSP40) HOMOLOG, SUBFAMILY B, MEMBER 9
GEMIN4 DKFZP434B131 PROTEIN
HNRPA3 HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3
LEMD1 LEM DOMAIN CONTAINING 1
MCM2 MCM2 MINICHROMOSOME MANTEINANCE DEFICIENT 2, MITOTIN (S.CEREVISIAE)
NAP1L4 NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4
NSUN2 NOL1/NOL2/SUN DOMAIN FAMILY, MEMBER 2
PCAF P300/CBP-ASSOCIATED FACTOR
POLA2 POLYMERASE (DNA DIRECTED), ALPHA 2 (70KD SUBUNIT)
SMARCC1 SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1
SMARCD3 SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3
SNAPC4 SMALL NUCLEAR RNA ACTIVATING COMPLEX, POLYPEPTIDE 4, 190KDA
SNRPB2 SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B2
TOR1A TORSIN FAMILY 1, MEMBER A (TORSIN A)
YY1 YY1 TRANSCRIPTION FACTOR
doi:10.1371/journal.pone.0014221.t002
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UV and c irradiation, heat shock, cyclohexamide, viral infection,
heavy metals, indicating that these elements may play an important
role in cancer etiology [35–40]. Moreover, despite the great
majority of LINE-1 are retrotranspositionally inactive due to 59
truncations, active transcription and translation of these elements
have been recently detected in a variety of cell types and implicated
as a potential regulator for cellular processes [41–43].
Here we show that in prostate cancer cells ABC treatment
induces a dose- and time-dependent increase of LINE-1 ORF1
and ORF2 transcripts. At present we cannot determine how the
inhibition of the LINE-1 cDNA elongation could cause an increase
of the ORF1 and ORF2 transcripts, nor if the increase is due to a
bona fide transcription induction or to a stabilization of LINE-1
mRNAs. Further investigations are required to elucidate the
molecular mechanism underlying this phenomenon.
Nevertheless, our results are consistent with previous studies
demonstrating how in cancer cells an increase in LINE-1
expression, obtained by synthetic constructs, has a genome-
destabilizing effect, inducing impairment in cell cycle progression
that leads to a senescence-like state [44,45]. In addition, even if
active cell divisions are required for LINE-1 retrotransposition
[46], a number of evidence suggests that this event itself is not
needed to cause ‘‘toxicity’’. In fact, the overexpression of an ORF2
construct alone is able to reduce the number of viable cells [47].
Interestingly, a recent study by Belancio et al. [48] shows that in
normal human fibroblasts immortalized with hTERT, exogenous
induction of LINE-1 expression (full-length or spliced ORF2
mRNA) leads to a senescence-like phenotype as a consequence of
DNA damage. Beside its role of reverse transcriptase, ORF2 also
encodes for the endonuclease activity known to induce DNA
double strand breaks [44,48].
Figure 7. Impact of ABC treatment on LINE-1 mRNA expression. Relative levels of LINE-1 mRNA transcripts (ORF1 and ORF2) in PC3 and
LNCaP cells treated with 15 and 150 mM ABC at different time points. Data are expressed as mean 6 SD. The (*) and (**) symbols denote a significant
difference compared to untreated cells, with a p value ,0.05 and ,0.01 respectively.
doi:10.1371/journal.pone.0014221.g007
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modification in gene expression independently of retrotransposi-
tion, this implies a more important role for LINE-1 products
(mRNAs, cDNAs, proteins). Actually, little is known about the
genetic interaction of LINE-1 with other genes within the
mammalian genome or the complex molecular mechanisms
regulating LINE-1 activity. In silico studies of the human genome
have shown that LINE-1 may coordinate gene transcription by
providing regulatory sequences that control gene expression or
silencing. [43,49–51].
In conclusion, we propose ABC as an anticancer agent able to
selectively affect multiple cellular functions and trigger senescence
in PC3 and LNCaP cells. We also suggest that ABC-induced
senescence may be related to the up-regulation of LINE-1
transcripts in prostate cancer cells. Our findings strongly support
the emerging concept of endogenous RT as an attractive target in
cancer therapy, providing an innovative strategy to circumvent the
difficulties related to the genetic heterogeneity of cancer
phenotypes. It would be interesting to evaluate in preclinical
studies the efficacy of ABC in combination with docetaxel, a
chemotherapeutic agent used in hormone-refractory metastatic
prostate cancer. Since Abacavir is clinically approved for human
use in AIDS therapy, drug repositioning in prostate and, possibly,
in other cancer forms resistant to current therapies, could
accelerate the traditional drug development.
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